Recent lecture of Irving Weissman focuses on possibilities of selective targeting of leukemic stem cell in human by manipulation of surface molecule – CD47.
Irving Weissman – Professor of Pathology and Developmental Biology at Stanford University and Director of the Stanford Comprehensive Cancer Center and Stanford Institute for Stem Cell Biology and Regenerative Medicine.
******************
also read:
How to train the immune system to kill cancer stem cells?
Cancer stem cells – how mouse model can change the concept
Complexity of cancer stem cells
Validity of the cancer stem cell concept under discussion
also watch:
Sean Morrison – Stem cell and cancer
Robert Weinberg – Cancer stem cells and malignant progression
Catriona Jamieson – The molecular evolution of leukemic stem cells
Irving Weissman – Stem Cells: Units in Regeneration, Cancer, and Natural Selection
————————
Connotea tags: cancer stem cell, CD47, Weissman IL
Related posts:
- Lecture: Irving Weissman – Stem Cells: Units in Regeneration, Cancer, and Natural Selection
- Lecture: Irving Weissman – The Politics and Promise of Stem Cell Research
- Reviews: The origins of the identification and isolation of hematopoietic stem cells by Irving Weissman
- Lecture: Sean Morrison – Stem cell and cancer
- Lecture: Robert Weinberg – Cancer stem cells and malignant progression
